Search Results 281-290 of 7482 for albumin

1. Study of HPN536 in Patients with Advanced Cancers Associated With Mesothelin Expression - Mayo Clinic

   Serum albumin ≥ 30 mg/mL. Exclusion Criteria: Previously treated or current brain metastases. Note: Patients with previously treated brain metastases may ...

2. Lower or Standard Dose Regorafenib in Treating Patients With Refractory Metastatic Colorectal Cancer - Mayo Clinic

   Albumin levels > 2.5; Any of the following: Pregnant women; Nursing women; Men or women of childbearing potential who are unwilling to employ adequate ...

3. Alina M. Allen, M.D. - Doctors and Medical Staff - Mayo Clinic

   Alina Allen, M.D., has a clinical and research interest in nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH).

4. Bladder Removal Surgery Clinical Trials - Mayo Clinic Research

   Maintenance therapy, such as paclitaxel albumin-stabilized nanoparticle formulation, can help keep cancer from coming back after it has disappeared following ...

5. Study of RYZ101 Compared With SOC in Pts With Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy - Mayo Clinic

   * Serum albumin ≥3.0 g/dL unless prothrombin time is within the normal range. Subjects who meet any of the following criteria will be excluded from the ...

6. Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis - Mayo Clinic

   Albumin ≥2.5 g/dL during screening; Serum creatinine ≤1.5 mg/dL during screening. Exclusion Criteria: Evidence of severe decompensation. Non-cirrhotic ...

7. A Registry and Biospecimen Collection to Advance the Diagnosis and Care of Patients with Glomerular Diseases - Mayo Clinic

   Aim 2 (Biomarkers). To identify and characterize clinical, histological, molecular, and genetic biomarkers that are linked to glomerular disease, disease ...

8. FT516 in Subjects With Advanced Hematologic Malignancies - Mayo Clinic

   Known allergy to the following FT516 components: albumin (human) or DMSO. Presence of any medical or psycho-social issues that are likely to interfere with ...

9. An Extension Study MRI/US Fusion Imaging and Biopsy in Combination With Nanoparticle Directed Focal Therapy for Ablation of Prostate Tissue - Mayo Clinic

   -Patients with acute or chronic hepatic dysfunction as evidenced by clinically important (> grade 1) changes in AST, ALT, bilirubin, or albumin, or either ALP ...

10. A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer (MERU) - Mayo Clinic

    Albumin ≥ 3 g/dL. If female, subject must be either postmenopausal as defined as: Age > 55 years with no menses for 12 or more months without an ...